Christofer Lendel

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 3 CIPO patents and 7 EPO patents, primarily in Polypeptide Research. Top assignees: Affibody Ab, General Electric Company. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christofer Lendel. Retrieved from https://idiyas.com/inventor/christofer-lendel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 83.3

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 5.8

ph-index = 3

Forward Citations = 35(Granted Patents)

Company Filing History:

General Electric Company

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

HER2 Binders

Polypeptide Libraries

Biokinetics

Affinity

Protein A

PDGF

IGF-1R

Fast-Clearing Polypeptides

Scaffold

Polypeptide Research

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12653913 - HER2 BINDERS (2026-06-16),

2. 11633507 - HER2 binders (2023-04-25),

3. 10894097 - HER2 binders (2021-01-19),

4. 10556933 - Polypeptide libraries with a predetermined scaffold (2020-02-11),

5. 10159760 - HER2 binders (2018-12-25),

6. 9469670 - Polypeptide libraries with a predetermined scaffold (2016-10-18),

7. 9238810 - Polypeptide (2016-01-19),

8. 9187535 - Polypeptide derived from protein A and able to bind PDGF (2015-11-17),

9. 8937047 - Biokinetics of fast-clearing polypeptides (2015-01-20),

10. 8883120 - Polypeptides having affinity for HER2 (2014-11-11),

11. 8501909 - Polypeptides having affinity for HER2 (2013-08-06),

12. 8426557 - IGF-1R binding polypeptides and their use (2013-04-23),

Title: Innovator Christofer Lendel's Contributions to Imaging Agents

Introduction

Christofer Lendel is a notable inventor hailing from Farsta, Sweden. With an impressive portfolio of 11 patents, Lendel has made significant advancements in the field of medical imaging. His groundbreaking work on HER2 binders demonstrates his commitment to innovation and enhancing diagnostic techniques.

Latest Patents

Among Lendel's notable patents is a series focused on HER2 binders, which are essential imaging agents that comprise an isolated polypeptide. These agents are conjugated with a radionuclide and a chelator, enabling specific binding to HER2 or its variants. The patents also outline methods for preparing and utilizing these imaging agents, showcasing Lendel's ingenuity in overcoming complex challenges in medical diagnostics.

Career Highlights

Throughout his career, Christofer Lendel has worked with distinguished companies, including Affibody AB and General Electric Company. His experiences in these organizations have equipped him with a robust understanding of biotechnology and imaging technologies, further propelling his innovative contributions in the industry.

Collaborations

Lendel has collaborated closely with esteemed colleagues, such as Joachim Feldwisch and Nina Herne. Their collective efforts have fueled advancements in the development of imaging agents and other related technologies, underscoring the significance of teamwork in the realm of innovation.

Conclusion

Christofer Lendel's impressive body of work and numerous patents reflect his dedication to improving medical imaging techniques. His innovations in HER2 binders are paving the way for enhanced diagnostic tools in healthcare, making him an influential figure in the field. As he continues to advance technology, his contributions will undoubtedly leave a lasting impact on the industry.

Profile summary based on public USPTO records.